These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 7792738

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A, Roisenberg I.
    Thromb Haemost; 1999 Mar; 81(3):475-6. PubMed ID: 10102489
    [No Abstract] [Full Text] [Related]

  • 43. Acquired hemophilia and its treatment.
    Sultan Y.
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [Abstract] [Full Text] [Related]

  • 44. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM, Ludlam CA.
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Suggestions for the management of factor VIII inhibitors.
    Rubinger M, Rivard GE, Teitel J, Walker H, Inhibitor Subcommittee of the Association of Hemophilia Clinic Directors of Canada.
    Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study.
    Miller CH, Rice AS, Boylan B, Shapiro AD, Lentz SR, Wicklund BM, Kelly FM, Soucie JM, Hemophilia Inhibitor Research Study Investigators.
    J Thromb Haemost; 2013 Jul; 11(7):1300-9. PubMed ID: 23601690
    [Abstract] [Full Text] [Related]

  • 51. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
    Hoyer LW, Scandella D.
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):1-5. PubMed ID: 7524160
    [No Abstract] [Full Text] [Related]

  • 52. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay.
    Pezeshkpoor B, Berkemeier AC, Herbst K, Albert T, Müller J, Oldenburg J.
    J Thromb Haemost; 2024 Jun; 22(6):1591-1604. PubMed ID: 38453023
    [Abstract] [Full Text] [Related]

  • 53. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS.
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [Abstract] [Full Text] [Related]

  • 54. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J.
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [Abstract] [Full Text] [Related]

  • 55. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J.
    Arch Immunol Ther Exp (Warsz); 2005 Oct; 53(4):352-6. PubMed ID: 16088320
    [Abstract] [Full Text] [Related]

  • 56. Von Willebrand factor-specific antibodies developing upon treatment of FVIII-deficient mice with different FVIII preparations.
    Kallas A, Kuuse S, Maimets T, Pooga M.
    Acta Haematol; 2008 Oct; 119(4):244-7. PubMed ID: 18594135
    [No Abstract] [Full Text] [Related]

  • 57. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM, Bernstein Z, Ghesani S, Shamsipour Z, Frances C, Zucker ML, LaDuca FM.
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [Abstract] [Full Text] [Related]

  • 58. Factor VIII inhibitors.
    Gilles JG, Jacquemin MG, Saint-Remy JM.
    Thromb Haemost; 1997 Jul; 78(1):641-6. PubMed ID: 9198231
    [No Abstract] [Full Text] [Related]

  • 59. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J, de Wit M, Fiedler W, Marx G, Hossfeld DK.
    Schweiz Med Wochenschr; 1996 Nov 23; 126(47):2026-31. PubMed ID: 8984611
    [Abstract] [Full Text] [Related]

  • 60. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
    Singer ST, Addiego JE, Reason DC, Lucas AH.
    Thromb Haemost; 1996 Jul 23; 76(1):17-22. PubMed ID: 8819245
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.